长江口外低氧区及其邻近海域表层沉积物反硝化微生物多样性和分布特征

【目的】微生物参与的反硝化是河口区氮损失的主要途径。【方法】本研究采用Illumina MiSeq测序方法,研究了长江口外低氧区及其邻近海域表层沉积物中nirS型和nirK型反硝化微生物群落的多样性和分布特征。【结果】样品共检测到346个nirS Operational Taxonomic Units和267个nirK Operational TaxonomicUnits,根据采样地的环境特征及nirS型和nirK型反硝化微生物群落聚类分析结果将所有OperationalTaxonomicUnits划分为低氧区、南部区域及外部深水区,其中外部深水区的样品nirS功能基因的多样性最高。各实验样地优势Operational Taxonomic Units在系统进化关系上可分为多个不同的簇。此次发现的所有优势OperationalTaxonomicUnits均属于未被培养的菌群,其中部分Operational Taxonomic Units还是首次被发现。此外还发现nirS功能基因对低氧区的环境适应性更好。【结论】我们的研究结果表明广泛存在的反硝化微生物在河口沉积物的氮循环中发挥重要作用。     

冰川细菌冷杆菌属的多样性研究进展

冰川作为地球主要的冰冻圈环境之一,蕴藏着丰富的低温微生物资源。1976年,Inoue Komagata从南极分离出一株嗜冷细菌,直到1997年,以这株嗜冷菌为模式物种,建立了冷杆菌属(Cryobacterium),同时该菌株被命名为嗜冷冷杆菌(Cryobacterium psychrophilum)。冷杆菌属物种主要分布于南北极、青藏高原冻土、冰川等低温环境,但与冰川等环境中其他常见类群相比丰度较低,属于稀有类群。目前,该属已有15个有效描述种,其中包含严格的嗜冷菌,但不同种对温度的耐受性有差异,因此是研究低温环境细菌进化和物种形成的良好材料。该属菌株可产生β-类胡萝卜素、低温酶等生物活性物质。本文综述了冷杆菌属的分布、生物学特征;通过对GenBank中冷杆菌属纯培养菌株的全基因组序列进行平均核酸序列一致性(average nucleotide identity,ANI)计算和聚类分析,明确其精确的分类地位,评估了该类群物种多样性;并讨论了冷杆菌在食品加工、医药卫生所需的生物活性物质的应用潜力。     

蓝藻挥发物α-紫罗酮诱导莱茵衣藻细胞程序性死亡

【目的】蓝藻挥发性有机化合物(VOCs)对其他藻类的化感作用可促进蓝藻成为富营养化水体优势种群,本研究旨在以VOCs主要成分α-紫罗酮为例揭示其化感致死机制。【方法】采用α-紫罗酮处理莱茵衣藻,测定藻细胞生长以及致死浓度下藻细胞光合性能、caspase-likes活性和DNA ladders。【结果】采用0.05和0.1mmol/Lα-紫罗酮处理24h后,莱茵衣藻细胞生长均受到明显抑制,其中0.1 mmol/L处理时部分藻细胞发生死亡,死亡率为38.3%。采用0.2 mmol/Lα-紫罗酮处理时,藻细胞全部死亡,同时光合色素逐渐降解、Fv/Fm逐渐降低并消失,这表明藻细胞死亡并非坏死。在藻细胞死亡过程中,caspase-9-like和caspase-3-like活性明显增强;DNA在处理1h时出现ladders,并逐渐降解为100–250 bp片段。【结论】这表明蓝藻VOCs可通过诱导细胞程序性死亡以发挥化感作用。     

Decreased reticuloendothelial system clearance and increased blood half-life and immune cell labeling for nano- and micron-sized superparamagnetic iron-oxide particles upon pre-treatment with Intralipid

Background

Superparamagnetic iron-oxide nanoparticles are useful as contrast agents for anatomical, functional and cellular MRI, drug delivery agents, and diagnostic biosensors. Nanoparticles are generally cleared by the reticuloendothelial system (RES), in particular taken up by Kupffer cells in the liver, limiting particle bioavailability and in-vivo applications. Strategies that decrease the RES clearance and prolong the circulation residence time of particles can improve the in-vivo targeting efficiency.

Methods

Intralipid 20.0%, an FDA approved nutritional supplement, was intravenously administered in rats at the clinical dose (2 g/kg) 1 h before intravenous injection of ultra-small superparamagnetic iron-oxide (USPIO) or micron-sized paramagnetic iron-oxide (MPIO) particles. Blood half-life, monocyte labeling efficiency, and particle biodistribution were assessed by magnetic resonance relaxometry, flow cytometry, inductively-coupled plasma MS, and histology.

Results

Pre-treatment with Intralipid resulted in a 3.1-fold increase in USPIO blood half-life and a 2-fold increase in USPIO-labeled monocytes. A 2.5-fold increase in MPIO blood half-life and a 5-fold increase in MPIO-labeled monocytes were observed following Intralipid pre-treatment, with a 3.2-fold increase in mean iron content up to 2.60 pg Fe/monocyte. With Intralipid, there was a 49.2% and 45.1% reduction in liver uptake vs. untreated controls at 48 h for USPIO and MPIO, respectively.

Conclusions

Intralipid pre-treatment significantly decreases initial RES uptake and increases in-vivo circulation and blood monocyte labeling efficiency for nano- and micron-sized superparamagnetic iron-oxide particles.

General significance

Our findings can have broad applications for imaging and drug delivery applications, increasing the bioavailability of nano- and micron-sized particles for target sites other than the liver.     

Structural insights into the functions of the FANCM-FAAP24 complex in DNA repair

Fanconi anemia (FA) is a genetically heterogeneous disorder associated with deficiencies in the FA complementation group network. FA complementation group M (FANCM) and FA-associated protein 24 kDa (FAAP24) form a stable complex to anchor the FA core complex to chromatin in repairing DNA interstrand crosslinks. Here, we report the first crystal structure of the C-terminal segment of FANCM in complex with FAAP24. The C-terminal segment of FANCM and FAAP24 both consist of a nuclease domain at the N-terminus and a tandem helix-hairpin-helix (HhH)₂ domain at the C-terminus. The FANCM-FAAP24 complex exhibits a similar architecture as that of ApXPF. However, the variations of several key residues and the electrostatic property at the active-site region render a catalytically inactive nuclease domain of FANCM, accounting for the lack of nuclease activity. We also show that the first HhH motif of FAAP24 is a potential binding site for DNA, which plays a critical role in targeting FANCM-FAAP24 to chromatin. These results reveal the mechanistic insights into the functions of FANCM-FAAP24 in DNA repair.     

Obesity-related genetic variants, human pigmentation, and risk of melanoma

Previous biological studies showed evidence of a genetic link between obesity and pigmentation in both animal models and humans. Our study investigated the individual and joint associations between obesity-related single nucleotide polymorphisms (SNPs) and both human pigmentation and risk of melanoma. Eight obesity-related SNPs in the FTO, MAP2K5, NEGR1, FLJ35779, ETV5, CADM2, and NUDT3 genes were nominally significantly associated with hair color among 5,876 individuals of European ancestry. The genetic score combining 35 independent obesity-risk loci was significantly associated with darker hair color (beta-coefficient per ten alleles = 0.12, P value = 4 × 10^?5). However, single SNPs or genetic scores showed non-significant association with tanning ability. We further examined the SNPs at the FTO locus for their associations with pigmentation and risk of melanoma. Among the 783 SNPs in the FTO gene with imputation R ² quality metric >0.8 using the 1,000 genome data set, ten and three independent SNPs were significantly associated with hair color and tanning ability respectively. Moreover, five independent FTO SNPs showed nominally significant association with risk of melanoma in 1,804 cases and 1,026 controls. But none of them was associated with obesity or in linkage disequilibrium with obesity-related variants. FTO locus may confer variation in human pigmentation and risk of melanoma, which may be independent of its effect on obesity.     

Sinomenine hydrochloride enhancement of the inhibitory effects of anti-transferrin receptor antibody-dependent on the COX-2 pathway in human hepatoma cells

Transferrin receptor (TfR) has been used as a target for the antibody-based therapy of cancer due to its higher expression in tumors relative to normal tissues. Great potential has been shown by anti-TfR antibodies combined with chemotherapeutic drugs as a possible cancer therapeutic strategy. In our study, we investigated the anti-tumor effects of anti-TfR monoclonal antibody (mAb) alone or in combination with sinomenine hydrochloride in vitro. Results suggested that anti-TfR mAb or sinomenine hydrochloride could induce apoptosis, inhibit proliferation, and affect the cell cycle. A synergistic effect was found in relation to tumor growth inhibition and the induction of apoptosis when anti-TfR mAb and sinomenine hydrochloride were used simultaneously. The expression of COX-2 and VEGF protein in HepG2 cells treated with anti-TfR mAb alone was increased in line with increasing dosage of the agent. In contrast, COX-2 expression was dramatically decreased in HepG2 cells treated with sinomenine hydrochloride alone. Furthermore, we demonstrated that the inhibitory effects of sinomenine hydrochloride and anti-TfR mAb administered in combination were more prominent than when the agents were administered singly. To sum up, these results showed that the combined use of sinomenine hydrochloride and anti-TfR mAb may exert synergistic inhibitory effects on human hepatoma HepG2 cells in a COX-2-dependent manner. This finding provides new insight into how tumor cells overcome the interference of iron intake to survive and forms the basis of a new therapeutic strategy involving the development of anti-TfR mAb combined with sinomenine hydrochloride for liver cancer.     

Efficacy of postoperative adjuvant transfusion of cytokine-induced killer cells combined with chemotherapy in patients with colorectal cancer

Purpose

To assess the activity and safety of postoperative adjuvant immunotherapy with transfusion of cytokine-induced killer (CIK) cells combined with chemotherapy in patients with colorectal cancer.

Methods

We retrospectively studied 96 consecutive patients with colorectal cancer who were treated with resection between January 2010 and December 2012 as well as adjuvant chemotherapy. Twenty-one of these patients accepted at least 1 cycle of CIK cell transfusion for immunotherapy (CIK group). Disease free survival (DFS), immune cells and treatment related side effects were assessed. The patients were followed up until May 2013.

Results

By the end of follow-up, 10 patients (10.42 %) had died. Eighteen patients (18.75 %) had withdrawn. All the patients in the CIK group are still alive, and only 1 patient had withdrawn. Patients in the CIK group had significantly longer DFS than those in the control group [HR = 0.28, 95 % CI (0.09, 0.91), p = 0.034]. The 2-year DFS rates of patients in the CIK group and the control group were 59.65 ± 24.80 % and 29.35 ± 6.39 %, respectively. The CD4⁺/CD8⁺ ratios were significantly lower during the period of chemotherapy than those before chemotherapy (p = 0.0038), while the ratios were significantly higher during the period of CIK cell transfusion than those before CIK therapy (p = 0.0484). There were no immediate adverse reactions to the CIK cell transfusions.

Conclusion

Adjuvant transfusion of CIK cells prolongs DFS in patients with colorectal cancer.     

Apobec-1 Increases Cyclooxygenase-2 and Aggravates Injury in Oxygen-Deprived Neurogenic Cells and Middle Cerebral Artery Occlusion Rats

Given that cyclooxygenase-2 (COX-2) plays a crucial role during cerebral ischemia and Apobec-1 is a critical regulator of COX-2 mRNA stabilization in gastrointestinal settings, the correlation of COX-2 and Apobec-1 was investigated in neurogenic cells and rat model of cerebral ischemia. After neurogenic SH-SY5Y, NG108-15 and PC12 cells were exposed to oxygen-glucose deprivation, cell viability, LDH leakage and Apobec-1 expression were determined. The effect of Apobec-1 overexpression on injury severity of oxygen-glucose deprivation, COX-2 expression, C-to-U editing of COX-2 mRNA were measured in vitro. Then the correlation of Apobec-1 level and injury severity was analyzed in cells with oxygen-glucose deprivation and in rats with middle cerebral artery occlusion. Apobec-1 expression was elevated along with upregulation of COX-2 and injury severity of oxygen-glucose deprivation in the three cell lines. Apobec-1 overexpression aggravated injury of oxygen-glucose deprivation in vitro and could be correlated to injury severity in vivo. Meanwhile, Apobec-1 increased COX-2 expression and COX-2 mRNA stabilization in neurogenic cells, and failed to catalyze C-to-U editing of COX-2 mRNA. Apobec-1 could upregulate COX-2 expression in neurogenic cells by stabilizing COX-2 mRNA, and might aggravate injury of oxygen-glucose deprivation in neurogenic cells as well as in rats with cerebral ischemia.     

大鼠海马CA1区神经元Na~+通道在出生后早期发育的变化

为了探索大鼠海马CA1区锥体神经元电压门控性Na+通道发育的关键期,本研究采用膜片钳技术,分别对急性分离的出生后0周、1周、2周、3周、4周的大鼠海马CA1区锥体神经元进行全细胞记录。结果显示,随着大鼠出生后周龄的增大,Na+通道的最大电流密度逐渐增大,出生后1~4周相对于出生后0周的最大电流密度的增幅分别为(42.76±4.91)%、(146.80±7.63)%、(208.79±5.28)%、(253.72±5.74)%(n=10,P<0.05),出生后1周与2周之间的增幅最为显著;Na+通道的稳态激活曲线向左移动,出生后0~2周的半数激活电压逐渐减小,分别为39.06±0.65、43.41±0.52、48.29±0.45(mV,n=10,P<0.05),出生后2~4周的半数激活电压变化不大,出生后0~4周的斜率因子没有显著变化;Na+通道的稳态失活曲线及半数失活电压没有显著变化,但出生后1~2周斜率因子减小,分别为5.77±0.56、4.42±0.43(n=10,P<0.05),出生后0~1周、2~4周之间的斜率因子没有明显变化;Na+通道失活后恢复曲线左移,出生后1~3周的恢复时间常数逐渐减小,分别为8.30±0.24、7.15±0.21、6.18±0.25(ms,n=10,P<0.05),而出生后0~1周、3~4周之间没有明显变化;随着出生后的发育,海马CA1区锥体神经元动作电位发生变化,超射值与最大上升速率增大,阈值降低,与Na+电流的变化一致。结果提示,出生后1~2周可能是电压门控性Na+通道发育的关键期,此期间Na+通道分布显著增加,激活曲线左移,失活速度变快,失活后恢复的时间缩短。